🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the immunogenicity, safety, and re...
Status
Completed
Location
Pinnacle Research Group-409 E 10th St
Start Date
2023-10-19
Trial ID
NCT06097273
Treatments Being Tested
The main purpose of this Phase II study was to assess the safety and immuno...
Status
Completed
Location
Investigational Site Number :8400003
Start Date
2021-07-16
Trial ID
NCT04969276
Treatments Being Tested
The primary goal of this study is to evaluate the safety and reactogenicity...
Status
Completed
Location
Accel Research Sites
Start Date
2022-10-14
Trial ID
NCT05585632
Treatments Being Tested
The primary objectives of the study are: * To describe the safety profile ...
Status
Terminated
Location
Investigational Site Number :8400003
Start Date
2021-03-12
Trial ID
NCT04798027
The primary objectives of the study are: To assess the safety profile of t...
Status
Completed
Location
Synexus - Clinical Research Advantage, Inc. Site Number : 8400270
Start Date
2021-02-24
Trial ID
NCT04762680
Treatments Being Tested
This phase 2 clinical trial will evaluate the safety and immunogenicity of ...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic
Start Date
2022-03-30
Trial ID
NCT05289037
Treatments Being Tested
This study will compare the safety and tolerability of lyophilized BNT162b2...
Status
Completed
Location
Anaheim Clinical Trials, LLC
Start Date
2021-04-01
Trial ID
NCT04816669
Treatments Being Tested
Primary#Objectives #Immunogenicity:To demonstrate the non-inferiority of bi...
Status
Unknown
Location
Savannakhét Provincial hospital
Start Date
2022-10-19
Trial ID
NCT05686161
Treatments Being Tested
This study is a non-randomized observation and comparison of immune respons...
Status
Recruiting
Location
Shoklo Malaria Research Unit (SMRU)
Start Date
2023-04-15
Trial ID
NCT05571735
Treatments Being Tested
Primary Immunogenicity Objective：Cohort 1: GMTs of SARS-CoV-2 Omicron and r...
Status
Unknown
Location
Multiple Locations
Start Date
2023-06-20
Trial ID
NCT05911087